<DOC>
	<DOCNO>NCT00638508</DOCNO>
	<brief_summary>After surgery normal experience pain site operation . In order reduce pain , medication Morphine inject vein use Patient Controlled Analgesia ( PCA ) pump keep bed side , activate patient need . However , Morphine opioid drug , cause side effect sedation , nausea , vomiting , reduce breathe prolong use . In addition opioid drug , local anesthetic , drug call Non steroidal anti inflammatory drug ( NSAIDs ) inject locally provide prolonged pain relief without side effect morphine . Recently portable device call ON-Q pump develop continuously infuse local anesthetic 2 small catheter insert wound site . The ON-Q Pump small tennis ball size unit make soft synthetic material slowly infuse drug catheter elastic force . This pump safe attach bedside pole patient 's hospital gown . This pump already approve FDA clinical use , report provide effective pain management surgical procedure . The primary aim present study evaluate relative efficacy drug Ketorolac Ropivacaine infuse ON-Q pump reduce pain follow gynecologic surgery . Ketorolac Ropivacaine approve drug frequently use post operative pain relief . Our hypothesis two drug combination provide good analgesia Ketorolac alone .</brief_summary>
	<brief_title>ON-Q Pump Infusion Ketorolac Ropivacaine Wound Site Postoperative Pain Management</brief_title>
	<detailed_description>This study would include total 60 patient randomize 2 equal group . Patients interview hold area inform sign consent obtain . Patients induced general anesthesia keep standard practice . At end surgical procedure , patient extubated , Surgeon secure 2 catheter ON-Q pump two level fascia near incision site . First surgeon instill wound site bolus dose 30 ml 0.9 % saline 10 mg Ketorolac Group I , 30 ml saline 0.5 % Ropivacaine 10 mg Ketorolac Group II patient . Then continuous infusion ON-Q pump start 4 ml/hr , Group I patient receive saline Ketorolac 5 mg/hr exceed 120 mg per day , Group II receive saline 0.5 % Ropivacaine plus Ketorolac 5 mg/hr . Patients extubated , per standard anesthetic practice . All patient receive anti ulcer medication . On arrival Post Anesthesia Care Unit ( PACU ) , patient receive i.v . PCA pump , administer Morphine Sulfate 2 mg incremental dos demand patient . A blinded investigator collect study data patient 6 , 12 , 24 , 48 hr postoperative period . The data collect would include 1 ) Visual Analog Scale ( VAS ) score pain rest , cough move , 2 ) PCA demand patient actual delivery morphine , 3 ) `` rescue '' analgesic requirement ( pain score 4 great ) . 4 ) VAS score Nausea , drowsiness , satisfaction , 5 ) number vomit .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>Patients belong ASA class I II classification undergo abdominal gynecologic surgery include study . Patients allergic NSAIDs , Asthmatics , peptic ulcer , sepsis , coagulation problem exclude study .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>